Literature DB >> 10364072

Stat6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells.

Y Khew-Goodall1, C Wadham, B N Stein, J R Gamble, M A Vadas.   

Abstract

Chronic upregulation of P-selectin expression on the surface of the endothelium has been observed in and likely contributes to a number of chronic inflammatory diseases, including atherosclerosis. Agonists of P-selectin expression fall into 2 categories: those that induce a very rapid, transient increase, lasting only hours, and those that induce prolonged upregulation lasting days. It is the latter group, which includes interleukin-4 (IL-4), that is likely to be a mediator of chronic P-selectin upregulation. The increase in P-selectin expression induced by IL-4 results from increased transcriptional activation of the P-selectin gene. The aim of this study was to deduce the postreceptor signaling pathway(s) giving rise to the prolonged increase in P-selectin expression induced by IL-4. We demonstrate the existence of 2 functional signal transducer and activator of transcription 6 (Stat6) binding sites on the P-selectin promoter and further demonstrate, by functional analysis of the P-selectin promoter, that binding of activated Stat6 to at least 1 site is essential for IL-4-induction of P-selectin transcription. Site 1 (nucleotide[nt] -142) bound Stat6 with a higher affinity than did site 2 (nt -229), and this difference was reflected functionally as constructs in which only site 1 was functional showed full IL-4 inducibility, whereas constructs in which only site 2 was functional showed only 40% of maximal IL-4 inducibility. IL-4 also induced prolonged activation of Stat6, which was contingent on the continuous presence of IL-4. The sustained activation of Stat6 induced by IL-4 is likely to be a key factor leading to the prolonged activation of the P-selectin promoter, thereby resulting in prolonged P-selectin upregulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364072     DOI: 10.1161/01.atv.19.6.1421

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor.

Authors:  Tatiana V Petrova; Taija Mäkinen; Tomi P Mäkelä; Janna Saarela; Ismo Virtanen; Robert E Ferrell; David N Finegold; Dontscho Kerjaschki; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

2.  STAT-6-mediated control of P-selectin by substance P and interleukin-4 in human dermal endothelial cells.

Authors:  Yasuhiro Miyazaki; Takahiro Satoh; Kiyoshi Nishioka; Hiroo Yokozeki
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  Helper T cells and atherosclerosis: the cytokine web.

Authors:  S G Baidya; Q-T Zeng
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

4.  The antidiabetic agent glibenclamide protects airway hyperresponsiveness and inflammation in mice.

Authors:  Wei Cui; Shufang Zhang; Zhijian Cai; Xinlei Hu; Ruifeng Zhang; Yong Wang; Na Li; Zhihua Chen; Gensheng Zhang
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

5.  Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4.

Authors:  R Clancy; Z Ren; G Pang; P Fletcher; C D'Este
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

6.  Genome-wide approaches reveal functional interleukin-4-inducible STAT6 binding to the vascular cell adhesion molecule 1 promoter.

Authors:  Hideto Tozawa; Yasuharu Kanki; Jun-ichi Suehiro; Shuichi Tsutsumi; Takahide Kohro; Youichiro Wada; Hiroyuki Aburatani; William C Aird; Tatsuhiko Kodama; Takashi Minami
Journal:  Mol Cell Biol       Date:  2011-04-04       Impact factor: 4.272

7.  Profibrotic Role for Interleukin-4 in Cardiac Remodeling and Dysfunction.

Authors:  Hongmei Peng; Zeyd Sarwar; Xiao-Ping Yang; Edward L Peterson; Jiang Xu; Branislava Janic; Nadia Rhaleb; Oscar A Carretero; Nour-Eddine Rhaleb
Journal:  Hypertension       Date:  2015-07-20       Impact factor: 10.190

8.  Role of leptin in atherogenesis.

Authors:  Laxman Dubey; Zeng Hesong
Journal:  Exp Clin Cardiol       Date:  2006

9.  Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis.

Authors:  Yuli Lin; Bingji Li; Xuguang Yang; Ting Liu; Tiancong Shi; Bo Deng; Yubin Zhang; Lijun Jia; Zhengfan Jiang; Rui He
Journal:  Mucosal Immunol       Date:  2019-09-18       Impact factor: 7.313

10.  Gene expression of adhesion molecules in endothelial cells from patients with peripheral arterial disease is reduced after surgical revascularization and pharmacological treatment.

Authors:  Franca Marino; Luigina Guasti; Matteo Tozzi; Laura Schembri; Luana Castiglioni; Elisabetta Molteni; Gabriele Piffaretti; Patrizio Castelli; Marco Cosentino
Journal:  Int J Vasc Med       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.